Mirati - oncology?

[anonymous]

Amen. Many leaders don’t put up with BS or drama and it’s hilarious to see the people who are fired or told they aren’t cutting it make up stories and broadcast as if they are truth.

The manger go down with the ship. Hahahahahahah. That man is me????

 

[anonymous]

Awe did you get your feelings hurt? All the criticisms, like it or not, are steeped in facts. None of which are a good look for the afore mentioned reprobates.

Nice try at deflecting the truth, a fairly common move for insecure narcissists who get called out on their crap.

I bet this gaslighting crotch weasel holds the door for Ben when he sees him walking in the building.

 

[anonymous]

Stock down another 4% today. Meek is as meek does.

Stock dropped again today. Over 20% down in last month now. Yeah, keep doing what you’re doing.

 

[anonymous]

Meek Loses Money (MLM)

Better ROI with doTERRA

 

[anonymous]

These insiders were all selling up in Jan and your telling me there is nothing to see here.
David Meek
Chief Executive Officer, Director
Laurie D. Stelzer
Chief Financial Officer
Alan Sandler
Executive Vice President, Chief Medical Officer
James G. Christensen
Chief Scientific Officer
Benjamin J. Hickey
Chief Commercial Officer
Bruce L. A. Carter
Independent Director
Julie M. Cherrington
Independent Director
Aaron I. Davis
Independent Director
Henry J. Fuchs
Independent Director

I heard the CEO of Silicon Valley Bank sold $3.6 million of stock right before that imploded too.

 

[anonymous]

Ask Meek about pushing opioids when he was at J&J

 

[anonymous]

Ask Meek about pushing opioids when he was at J&J

Ask Meek about his back pack tan at Diabetcut.

 

[anonymous]

Ask Meek about pushing opioids when he was at J&J

Breaking Bad

 

[anonymous]

BioCentury - The drug industry’s personalized medicine problem

The drug industry’s personalized medicine problem

Commercially, the challenge is becoming obvious. Targeted therapies approved for specific patient subsets based on biomarker testing appear to be underperforming. Sales of the extraordinary scientific and medical innovation from Amgen Inc.(NASDAQ:AMGN) Lumakras sotorasib, the first oral KRAS inhibitor, have been declining — less than two years after it was launched

 

[anonymous]

Ask Meek about his back pack tan at Diabetcut.

I think he was up in a tree at the time....

 

[anonymous]

BioCentury - The drug industry’s personalized medicine problem

The drug industry’s personalized medicine problem

Commercially, the challenge is becoming obvious. Targeted therapies approved for specific patient subsets based on biomarker testing appear to be underperforming. Sales of the extraordinary scientific and medical innovation from Amgen Inc.(NASDAQ:AMGN) Lumakras sotorasib, the first oral KRAS inhibitor, have been declining — less than two years after it was launched

Mirati’s future...

 

[anonymous]

I hope Meek has a good lawyer.

 

[anonymous]

I hope Meek has a good lawyer.

Monahan!

 

[anonymous]

The bonuses are paid and now people are leaving. Great launch!

 

[anonymous]

Who is leaving? Everything is so hush hush.

The bonuses are paid and now people are leaving. Great launch!

 

[anonymous]

Meek and his bad toupee must go.

 

[anonymous]

Who is leaving? Everything is so hush hush.

Monahan left. Damn shame. He good.

 

[anonymousw]

I hope Meek has a good lawyer.

Don’t drop the soap in the shower!

 

[anonymous]

Don’t drop the soap in the shower!

He go irish spring!

 

[anonymous]

Is Mirati going to give Meek over $1 billion to piss away on valueless business development deals like at Ipsen?